Use of a low-protein diet supplemented with amino acid ketoanalogues as part of a Drug Programme B.113. Clinical case reports

Chronic kidney disease (CKD) is an increasingly common condition associated with age, diabetes and hypertension. In addition to medication, nonpharmacological methods of kidney protection are used, which include lifestyle modifications. In this, the reduction of protein intake and the use of ketoanalogues of amino acids (KA) play an important role. Since 2021, a drug programme has been implemented in Poland for people with stage 4 and 5 CKD which includes the use of a low-protein diet and KA. The diet aims to reduce the production of uremic toxins, slow disease progression and improve patients’ quality of life.

Authors

Institutions

Publication Details

Journal
Renal Disease and Transplantation Forum.
Published
2024-11-21
DOI
https://doi.org/10.5603/rdatf.102754
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of a low-protein diet supplemented with amino acid ketoanalogues as part of a Drug Programme B.113. Clinical case reports

Magdalena Jankowska, Agnieszka Makówka, Hanna Augustyniak‐Bartosik, Ewelina Olczyk et al.
Renal Disease and Transplantation Forum.
Metabolism and Genetic Disorders
article

Use of a low-protein diet supplemented with amino acid ketoanalogues as part of a Drug Programme B.113. Clinical case reports

Magdalena Jankowska, Agnieszka Makówka, Hanna Augustyniak‐Bartosik, Ewelina Olczyk, P. Miarka, Sylwia Małgorzewicz, Katarzyna Błądek, Agnieszka Płuciennik
article en

Abstract

Chronic kidney disease (CKD) is an increasingly common condition associated with age, diabetes and hypertension. In addition to medication, nonpharmacological methods of kidney protection are used, which include lifestyle modifications. In this, the reduction of protein intake and the use of ketoanalogues of amino acids (KA) play an important role. Since 2021, a drug programme has been implemented in Poland for people with stage 4 and 5 CKD which includes the use of a low-protein diet and KA. The diet aims to reduce the production of uremic toxins, slow disease progression and improve patients’ quality of life.

Renal Disease and Transplantation Forum.Vol. 17(3)
Clinical Hospital No. 8 (RU), University Clinical Centre (PL), Central Clinical Hospital (PL), Krakow Cardiovascular Research Institute (PL), Gdańsk Medical University (PL), Fresenius Kabi (Czechia) (CZ), Fresenius Medical Care (Germany) (DE)
Zero hunger
Openalex Percentile: Top 63%
Metabolism and Genetic Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Use of a low-protein diet supplemented with amino acid ketoanalogues as part of a Drug Programme B.113. Clinical case reports — Magdalena Jankowska, Agnieszka Makówka, et al. · Renal Disease and Transplantation Forum. (2024) | TGRS Research Map | TGRS